Evidence map›Paper›PMID 24621506›Full record

ArticleCell cycle (Georgetown, Tex.)2014

Dissecting the first and the second meiotic divisions using a marker-less drug-hypersensitive fission yeast.

Yuki Aoi, Masamitsu Sato, Takashi Sutani, Katsuhiko Shirahige, Tarun M Kapoor, Shigehiro A Kawashima

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. An "In Schizo" Evaluation System to Screen for Human Kinesin-5 Inhibitors.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. cAMP export by the fission yeastmicroPublication biology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Yuki AoiGraduate School of Pharmaceutical Sciences; The University of Tokyo; Bunkyo-ku, Tokyo, Japan.
Masamitsu SatoDepartment of Life Science and Medical Bioscience; Graduate School of Advanced Science and Engineering; Waseda University; Shinjuku, Tokyo, Japan.
Takashi SutaniInstitute of Molecular and Cellular Biosciences; The University of Tokyo; Bunkyo-ku, Tokyo, Japan.
Katsuhiko ShirahigeInstitute of Molecular and Cellular Biosciences; The University of Tokyo; Bunkyo-ku, Tokyo, Japan.
Tarun M KapoorLaboratory of Chemistry and Cell Biology; Rockefeller University; New York, NY USA.
Shigehiro A KawashimaGraduate School of Pharmaceutical Sciences; The University of Tokyo; Bunkyo-ku, Tokyo, Japan.
Kumamoto University · JPDivision of Molecular & Cellular Biosciences · USRockefeller University · USShinjuku Yamabuki High School · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Faithful chromosome segregation during meiosis is indispensable to prevent birth defects and infertility. Canonical genetic manipulations have not been very useful for studying meiosis II, since mutations of genes involved in cell cycle regulation or chromosome segregation may affect meiosis I, making interpretations of any defects observed in meiosis II complicated. Here we present a powerful strategy to dissect meiosis I and meiosis II, using chemical inhibitors in genetically tractable model organism fission yeast (Schizosaccharomyces pombe). As various chemical probes are not active in fission yeast, mainly due to an effective multidrug resistance (MDR) response, we have recently developed a drug-hypersensitive MDR-sup strain by suppression of the key genes responsible for MDR response. We further developed the MDR-supML (marker-less) strain by deleting 7 MDR genes without commonly used antibiotic markers. The new strain makes fluorescent tagging and gene deletion much simpler, which enables effective protein visualization in varied genetic backgrounds. Using the MDR-supML strain with chemical inhibitors and live cell fluorescence microscopy, we established cell cycle arrest at meiosis I and meiosis II and examined Aurora-dependent spindle assembly checkpoint (SAC) regulation during meiosis. We found that Aurora B/Ark1 kinase activity is required for recruitment of Bub1, an essential SAC kinase, to unattached kinetochore in prometaphase I and prometaphase II as in mitosis. Thus, Aurora's role in SAC activation is likely conserved in mitosis, meiosis I, and meiosis II. Together, our MDR-supML strain will be useful to dissect complex molecular mechanisms in mitosis and 2 successive meiotic divisions.

Indexed as

Antifungal AgentsAurora KinasesBoronic AcidsBortezomibBrefeldin ACycloheximideDrug Resistance, Multiple, FungalMeiosisM Phase Cell Cycle CheckpointsPrometaphaseProtein Serine-Threonine KinasesPyrazinesSchizosaccharomycesSchizosaccharomyces pombe ProteinsAntifungal Agentsark1 protein, S pombeAurora KinasesBoronic AcidsBortezomibBrefeldin ABub1 protein, S pombeCycloheximideProtein Serine-Threonine KinasesPyrazinesSchizosaccharomyces pombe ProteinsAurora kinasechemical inhibitorsfission yeastmeiosismultidrug resistanceSACspindle assembly checkpoint

Identifiers

PMID24621506
PMCPMC4049969
OpenAlexW2011715895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.